These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7509261)

  • 1. Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses.
    Krzeski T; Kazón M; Borkowski A; Witeska A; Kuczera J
    Clin Ther; 1993; 15(6):1011-20. PubMed ID: 7509261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study].
    Barlet A; Albrecht J; Aubert A; Fischer M; Grof F; Grothuesmann HG; Masson JC; Mazeman E; Mermon R; Reichelt H
    Wien Klin Wochenschr; 1990 Nov; 102(22):667-73. PubMed ID: 1702916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urological and sexual evaluation of treatment of benign prostatic disease using Pygeum africanum at high doses].
    Carani C; Salvioli V; Scuteri A; Borelli A; Baldini A; Granata AR; Marrama P
    Arch Ital Urol Nefrol Androl; 1991 Sep; 63(3):341-5. PubMed ID: 1723220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trial.
    Melo EA; Bertero EB; Rios LA; Mattos D
    Int Braz J Urol; 2002; 28(5):418-25. PubMed ID: 15748367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of a combined Sabal-urtica preparation in the symptomatic treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
    Popa G; Hägele-Kaddour H; Walther C
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():103-8. PubMed ID: 16261945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of benign prostatic hyperplasia. Results of a treatment study with the phytogenic combination of Sabal extract WS 1473 and Urtica extract WS 1031 in urologic specialty practices].
    Schneider HJ; Honold E; Masuhr T
    Fortschr Med; 1995 Jan; 113(3):37-40. PubMed ID: 7534258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.
    Safarinejad MR
    J Herb Pharmacother; 2005; 5(4):1-11. PubMed ID: 16635963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma].
    Dufour B; Choquenet C; Revol M; Faure G; Jorest R
    Ann Urol (Paris); 1984 May; 18(3):193-5. PubMed ID: 6084978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tadenan (Pygeum africanum extract) in the treatment of patients with benign prostatic hyperplasia].
    Urologiia; 2004; (5):70-2. PubMed ID: 15560171
    [No Abstract]   [Full Text] [Related]  

  • 11. The inhibiting effects of Urtica dioica root extracts on experimentally induced prostatic hyperplasia in the mouse.
    Lichius JJ; Muth C
    Planta Med; 1997 Aug; 63(4):307-10. PubMed ID: 9270373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
    Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
    Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].
    Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM
    Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
    Xu J; Qian WQ; Song JD
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
    Maekawa M; Kishimoto T; Yasumoto R; Wada S; Harada T; Ohara T; Okajima E; Hirao Y; Ohzono S; Shimada K
    Hinyokika Kiyo; 1990 Apr; 36(4):495-516. PubMed ID: 1696065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
    Gratzke P; Kirby RS
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
    Breza J; Dzurny O; Borowka A; Hanus T; Petrik R; Blane G; Chadha-Boreham H
    Curr Med Res Opin; 1998; 14(3):127-39. PubMed ID: 9787978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group].
    Fourcade RO
    Prog Urol; 2000 Apr; 10(2):246-53. PubMed ID: 10857142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pygeum africanum extract inhibits proliferation of human cultured prostatic fibroblasts and myofibroblasts.
    Boulbès D; Soustelle L; Costa P; Haddoum M; Bali JP; Hollande F; Magous R
    BJU Int; 2006 Nov; 98(5):1106-13. PubMed ID: 17034612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.
    Nordling J
    BJU Int; 2005 May; 95(7):1006-12. PubMed ID: 15839922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.